AEON Biopharma, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2021 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
AEON Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2021 to 2022.
  • AEON Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $5M, a 16.7% decline year-over-year.
  • AEON Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $40.5M, a 85.4% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $40.5M -$237M -85.4% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2021 $278M Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.